Jazz Pharmaceuticals
JAZZ
JAZZ
318 hedge funds and large institutions have $7.03B invested in Jazz Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 85 increasing their positions, 134 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
24% less call options, than puts
Call options by funds: $106M | Put options by funds: $140M
37% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 134
Holders
318
Holding in Top 10
13
Calls
$106M
Puts
$140M
Top Buyers
| 1 | +$325M | |
| 2 | +$232M | |
| 3 | +$176M | |
| 4 |
Jennison Associates
New York
|
+$135M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$103M |
Top Sellers
| 1 | -$403M | |
| 2 | -$76.7M | |
| 3 | -$48.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$47M |
| 5 |
HCM
Hoplite Capital Management
New York
|
-$45.9M |